EUVIMEDEUVIMED entdecken
Crossref

Mechanisms of Hepatitis B Virus Resistance Development

Nadia Warner, Stephen Locarnini

Intervirology · 2014 · 57 (3-4) · 218-224

DOI: 10.1159/000360940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intervirology, online erschienen am 15.07.2014. Verfasst von Nadia Warner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory (VIDRL), North Melbourne, Vic., Australia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) resistance to nucleos(t)ide analogue (NA) therapy is essentially structure specific, with each NA falling within three main structural groups. Resistance to each of these is characterized by specific mutations in the reverse transcriptase domains of the HBV polymerase, and may be associated with compensatory mutations which can increase replication. HBV polymerase is considered to have a traditional ‘right-handed' structural conformation, and each of the resistance mutations is predicted to cause a specific structural change of the polymerase, thereby preventing incorporation of NA into replicating DNA. The selection of resistance occurs at different rates for each NA, and is affected by the high mutational rate of HBV and the ability of the drug to suppress viral replication. Some mutations or combinations of mutations may be associated with multidrug resistance, limiting treatment options. In contrast to most other viruses, resistance in HBV is confounded by the overlapping surface gene, the major NA-resistant mutations also altering the surface proteins in most cases, potentially altering virus secretion and neutralization, which may pose a public health threat in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenineAmino Acid SubstitutionAntiviral AgentsDeoxycytidineDrug Resistance, Multiple, ViralEmtricitabineGuanineHepatitis B Surface AntigensHepatitis B virusHepatitis B, ChronicHumansLamivudineOrganophosphonatesRNA-Directed DNA PolymeraseReverse Transcriptase InhibitorsTelbivudineTenofovirThymidineVirus Replication

Substanzen

Antiviral AgentsHepatitis B Surface AntigensOrganophosphonatesReverse Transcriptase InhibitorsDeoxycytidineTelbivudineLamivudineentecavirGuanineadefovir

Autor:innen und Institutionen

  • Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory (VIDRL), North Melbourne, Vic., Australia.

Zitieren

APA

Warner, N., & Locarnini, S. (2014). Mechanisms of Hepatitis B Virus Resistance Development. Intervirology, 57(3-4), 218-224. https://doi.org/10.1159/000360940

Vancouver

Warner N, Locarnini S. Mechanisms of Hepatitis B Virus Resistance Development. Intervirology. 2014;57(3-4):218-224. doi:10.1159/000360940

BibTeX
@article{Warner2014,
  author = {Warner, Nadia and Locarnini, Stephen},
  title = {Mechanisms of Hepatitis B Virus Resistance Development},
  journal = {Intervirology},
  year = {2014},
  volume = {57},
  number = {3-4},
  pages = {218--224},
  doi = {10.1159/000360940}
}
Kostenlos starten →